Biotech · Private company
Jiangsu Simcere Pharmaceutical Co., Ltd.
Track this companyFree. Adds Jiangsu Simcere Pharmaceutical Co., Ltd. to your Dealase workspace and tells you when its record changes.
Clinical trials31 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- SIM0237Phase 1 · Locally Advanced Unresectable or Metastatic Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
- SIM0500Phase 1 · Relapsed or Refractory Multiple MyelomaClinicalTrials.gov · fetched Nov 12, 2026
- SIM1811-03Phase 1 · Advanced Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Study of SIM0500 Alone in Participants With Relapsed or Refractory Multiple MyelomaPHASE1 · RECRUITING · started May 24, 2024ClinicalTrials.gov NCT06375044 · fetched Nov 12, 2026
- A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of SIM0237 in Adult Participants with Advanced Solid TumorsPHASE1 · TERMINATED · started Mar 8, 2023ClinicalTrials.gov NCT05781360 · fetched Nov 12, 2026
- A Phase I Trial of SIM1811-03 in Subjects With Advanced Solid Tumors and Cutaneous T-cell LymphomaPHASE1 · UNKNOWN · started Sep 30, 2022ClinicalTrials.gov NCT05569057 · fetched Nov 12, 2026